Middle East & Africa Influenza Vaccine Market Size & Outlook

Name: Middle East & Africa Influenza Vaccine Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The influenza vaccine market in Middle East & Africa is expected to reach a projected revenue of US$ 242.7 million by 2030. A compound annual growth rate of 7.6% is expected of Middle East & Africa influenza vaccine market from 2024 to 2030.

Pharmaceuticals
- Vaccines
  - Influenza Vaccine Market Outlook

Middle East & Africa influenza vaccine vaccine type outlook (Revenue, USD million, 2018-2030)
- Inactivated
- Live Attenuated
Middle East & Africa influenza vaccine indication outlook (Revenue, USD million, 2018-2030)
- Quadrivalent
- Trivalent
Middle East & Africa influenza vaccine age group outlook (Revenue, USD million, 2018-2030)
- Pediatric
- Adult
Middle East & Africa influenza vaccine route of administration outlook (Revenue, USD million, 2018-2030)
- Injection
- Nasal Spray
Middle East & Africa influenza vaccine distribution channel outlook (Revenue, USD million, 2018-2030)
- Hospitals & Pharmacy
- Government & Institutional supply
- Other Distribution Channels

Middle East & Africa Influenza Vaccine Market Size & Outlook

Data Tree

Sign up - it's easy, and free!